13

Revenue 2017

Bristol-Myers Squibb

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bristol-Myers Squibb's 2013 sales performance.

Keytruda hits survival targets in first-line kidney cancer

Bristol-Myers Squibb’s cancer immunotherapy pairing of PD-1 inhibitor Opdivo (nivolumab) and CTLA4 inhibitor Yervoy (ipilimumab) was approved earlier this year as first-line treatment for RCC, but only

Cancer disruptor F Star names next CEO

The company has deals with the likes of Bristol-Myers Squibb, Merck KGaA and AbbVie.

BMS finds a new immunotherapy partner with $12m Compugen deal

Combination with novel antibody targeting PVRIG pathway. Bristol Myers Squibb is continuing its tireless search for the perfect immunotherapy combination, today announcing a new $12m deal with Compugen. ... The collaboration is also designed to address

BMS finds a new immunotherapy partner with $12m Compugen deal

BMS finds a new immunotherapy partner with $12m Compugen deal. Bristol Myers Squibb is continuing its tireless search for the perfect immunotherapy combination, today announcing a new $12m deal with Compugen. ... The collaboration is also designed to

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 (Next 4)

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology

Featured jobs

Editorial Director – Medical Education: Neg

Account Director: Negotiable

Senior Account Manager - Med Comms: Highly Competitive Salary &Benefits

Scientific Director: Highly Competitive Salary &Benefits

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Associate Medical Director: Salary TBC

Senior Medical Writer (Remote Working): Competitive Salary Offered

Director – Head of Public Affairs: Neg

Project / Account Manager (Medical Education): Salary TBC

Account Director - Digital: Great salary and benefits

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Lead Medical Copywriter, Healthcare Brand Communications, London: Excellent package

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Associate Medical Director: Highly Competitive

Senior Account Manager / Account Director - Med Comms: Great salary and benefits

Experienced Editor, London, Medical Communications: Competitive package

Account Director – Global Healthcare PR: Salary TBC

Account Manager, Healthcare Communications: £32, 000 - £40, 000 benefits

Account Manager- Manchester, Macclesfield or Glasgow: Negotiable

Scientific Team Lead: Competitive Salary

Director Healthcare PR Communications: Salary TBC

Account Manager, Healthcare Advertising: Salary TBC

Senior Account Executive – Medical Communications: Salary TBC

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Medical Strategic Director, Healthcare Advertising Agency: Salary TBC

Retaining reader value in plain language summaries of clinical studies: Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?: Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Making Europe a leader in bioscience: boosting trust and opening minds: A vision of Paris as Europe's leading hub for life sciences innovation...